Skip to main content

AtriCure

AtriCure Inc is an American medical technology company specializing in the development, manufacture, and distribution of innovative surgical ablation systems, left atrial appendage management devices, and pain management solutions used primarily by cardiothoracic surgeons to treat atrial fibrillation and related cardiac disorders. The company designs and produces advanced radiofrequency ablation clamps, cryoablation devices, and exclusion systems utilized in open-heart and minimally invasive surgical procedures globally. Its core operations encompass biomedical device engineering, surgical instrument manufacturing, clinical education, and global wholesale distribution. Revenue is derived directly from the global wholesale sale of single-use surgical ablation devices and implantable medical equipment to hospitals and surgical centers. AtriCure holds a leading global market position in surgical treatment devices for atrial fibrillation. The company is headquartered in Mason, Ohio, United States, and its common stock trades on the Nasdaq Global Select Market.

5 of the funds FundTelligence covers report a position in AtriCure.

Legal name
AtriCure Inc
Sector
Health Care
Country
United States
Funds holding it
5

Funds holding AtriCure

Loading...